THE admission from the Government that medicine supply chains could be disrupted for up to six months in the event of a no deal Brexit shows that it is starting to take seriously the consistent warnings from the BMA and others over the risk a no-deal poses to healthcare in Britain.
While measures to anticipate the risks and minimise impact on patients and their access to medicines must be put in place, with just over 100 days to go, ministers are cutting it extremely fine.
The difference between six weeks of disruption and six months of chaos on the borders is clearly huge and the scale of action now required to ensure the safety of patients is eminently much bigger.
That these plans are still only in the development stage with four months to go is extremely concerning and the lack of detail in these proposals will offer little in the way of reassurance to doctors and patients alike.
The BMA has been clear how catastrophic Brexit could be for patients, the NHS workforce and the health of